CLOVERNA

RNA targeted drug discovery

General Information
Company Name
CLOVERNA
Founded Year
2020
Location (Offices)
Japan +1
Founders / Decision Makers
Ito Tatsuo - Founder
Number of Employees
1
Industries
Biopharma, Biotechnology, Pharmaceutical
Funding Stage
-
Social Media

CLOVERNA - Company Profile

CLOVERNA is a biopharmaceutical company focused on RNA targeted drug discovery. The company's innovative platform utilizes RNA-targeted Drug Discovery technology to identify new RNA databases and drug candidates for treating rare diseases, offering renewed hope to patients. With a mission to uncover previously unavailable biology, CLOVERNA is dedicated to discovering revolutionary medicines and improving human health. The company was founded in 2022 and operates within the biopharma, biotechnology, and pharmaceutical industries. As of now, there is no publicly available information about their headquarters, last investment, or investors.

Taxonomy: Biopharmaceutical, RNA-targeted drug discovery, Rare diseases, Drug discovery platform, RNA databases, Drug candidates, Revolutionary medicines, Healthcare innovation, Biology, Precision medicine

Funding Rounds & Investors of CLOVERNA (0)

View All

There is no investment information

Latest News of CLOVERNA

View All

No recent news or press coverage available for CLOVERNA.

Similar Companies to CLOVERNA

View All
CLOVERNA - Similar company to CLOVERNA
CLOVERNA RNA targeted drug discovery
Arrakis Therapeutics - Similar company to CLOVERNA
Arrakis Therapeutics Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions of patients.
Envisagenics - Similar company to CLOVERNA
Envisagenics Artificial Intelligence, High Performance Computing, and RNA sequencing data to find cures faster than ever before.
Expansion Therapeutics - Similar company to CLOVERNA
Expansion Therapeutics Bringing transformative therapies to patients with severe RNA-mediated diseases.
Saverna Therapeutics AG - Similar company to CLOVERNA
Saverna Therapeutics AG Saverna Therapeutics aims to discover highly active, selective and cell-permeable molecules to target RNA biology
Circle Decoration Circle Decoration

Want to dive deeper into CLOVERNA? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now